China: Authorities issue regulation to strengthen supervision of medical insurance funds
Source: Asia Insurance Review | Jul 2023
China has formed a tough stance against medical insurance fraud and will strengthen its regulation on the use of medical insurance funds, according to a policy briefing held by the State Council on 9 June.
An implementation guideline on furthering regulation on the use of medical insurance funds has recently been released to tackle significant and difficult problems in this field, reported Xinhua News Agency.
The guideline urged efforts to strengthen the enforcement of rules covering medical insurance funds, improve the long-term regulatory mechanisms, and work faster to build a robust, safe, effective, and law-based routine regulatory system with clearly defined rights and responsibilities.
The National Healthcare Security Administration (NHSA) will implement the requirements of the document in terms of smart regulation, law-based administration, comprehensive evaluation systems, and policy publicity, said NHSA deputy head Yan Qinghui.
The NHSA and four other relevant departments have launched a nationwide campaign to crack down on medical insurance fraud. Up to April this year, Chinese authorities had inspected millions of designated medical institutions and recovered CNY80.5bn ($11.32bn) of medical insurance funds. A